Noluthando Mwelase

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

Susan Swindells, Ritesh Ramchandani, Amita Gupta et al. · New England Journal of Medicine · 2019 · 347 citations · Full text

Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial

Kelly E. Dooley, Richard Kaplan, Noluthando Mwelase et al. · Clinical Infectious Diseases · 2019 · 108 citations · Full text

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial

Susan E. Krown, Carlee Moser, Patrick MacPhail et al. · The Lancet · 2020 · 87 citations · Full text

Treatment And Prevention, Resource-limited Settings, Pathology +3

Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study

Mark W. Tenforde, Ashish Yadav, David W. Dowdy et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 40 citations

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial

Jean‐Michel Molina, Birgit Grund, Fred M. Gordin et al. · The Lancet HIV · 2018 · 35 citations · Full text

Primary Immunodeficiency, Epidemiology, Antiretroviral Therapy +13